# US 2009/0270635 A1 · Diphosphine Ligand and Transition Metal Complex Using the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270635 A1
- Document ID: US20090270635A1
- Status: Published application
- Kind: A1
- Application number: 11/992,167
- Filed: 2006-09-20
- Published: 2009-10-29
- Earliest claimed: 2005-09-20
- Assignees: Takeda Pharmaceutical Company Limited
- Inventors: Mitsuhisa Yamano; Mitsutaka Goto; Shinji Kawaguchi; Masatoshi Yamada; Jun-ichi Kawakami
- Web page: https://patentgrep.com/patent/US20090270635A1

## CPC

- C07F 9/572: Five-membered rings
- B01J 31/2452: {with more than one complexing phosphine-P atom}
- C07B 53/00: Asymmetric syntheses
- C07F 9/5022: {Aromatic phosphines (P-C aromatic linkage)}
- C07F 9/5027: {Polyphosphines}
- C07F 15/004: {without a metal-carbon linkage}
- C07F 15/0053: {without a metal-carbon linkage}
- C07F 15/0066: {without a metal-carbon linkage}
- C07F 15/008: {without a metal-carbon linkage}
- B01J 2531/80: Complexes comprising metals of Group VIII as the central metal
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention provides a novel ligand represented by the following formula and a novel transition metal complex having the ligand, which shows superior enantioselectivity and catalytic efficiency, particularly high catalyst activity, in various asymmetric synthesis reactions. A transition metal complex having, as a ligand, a compound represented by the formula wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula is a group represented by the formula wherein ring B is a 3- to 8-membered ring optionally having substituent(s).

## Claims

### Claim 1

A compound represented by the formula
wherein R1 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R2 and R3 are each a C1-6 alkyl group optionally having substituent(s), or the formula
is a group represented by the formula
wherein ring A is a 3- to 8-membered ring optionally having substituent(s), provided that 2,2′-bis[bis(4-dimethylaminophenyl)phosphino]-1,1′-binaphthyl is excluded, or a salt thereof.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R1, R2 and R3 are each a C1-6 alkyl group optionally having substituent(s).

### Claim 3 (depends on 1)

The compound of claim 1, wherein R1, R2 and R3 are each an unsubstituted C1-6 alkyl group.

### Claim 4 (depends on 1)

The compound of claim 1, which is 2,2′-bis[bis(4-dimethylamino-3,5-dimethylphenyl)phosphino]-1,1′-binaphthyl, 2,2′-bis[bis(4-dimethylamino-3,5-diethylphenyl)phosphino]-1,1′-binaphthyl or 2,2′-bis[bis(4-dimethylamino-3,5-diisopropylphenyl)phosphino]-1,1′-binaphthyl.

### Claim 5 (depends on 1)

The compound of claim 1, which is an optically active compound.

### Claim 6

A transition metal complex having, as a ligand, a compound represented by the formula
wherein R4 is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5 and R6 are each a C1-6 alkyl group optionally having substituent(s), or the formula
is a group represented by the formula
wherein ring B is a 3- to 8-membered ring optionally having substituent(s).

### Claim 7 (depends on 6)

The transition metal complex of claim 6, wherein the transition metal is rhodium, ruthenium, iridium, palladium, nickel or copper.

### Claim 8 (depends on 6)

The transition metal complex of claim 6, wherein the transition metal is rhodium, ruthenium or palladium.

### Claim 9 (depends on 6)

The transition metal complex of claim 6, wherein R4 is a hydrogen atom or an unsubstituted C1-6 alkyl group, and R5 and R6 are each an unsubstituted C1-6 alkyl group.

### Claim 10 (depends on 6)

The transition metal complex of claim 6, which is selected from the following:
(1) [Ru(OAc)2(L)];
(2) [RuCl2(L)(dmf)n];
(3) [RuCl(Ar)(L)]Cl;
(4) [Ru(2-methylallyl)2(L)];
(5) [RuCl2(L)(X)];
(6) (NH2Et2)[{RuCl(L)}2(μ-Cl)3];
(7) [Rh(Y)(L)]Z;
(8) [PdCl2(L)]; and
(9) [{Pd(L)}2(μ-OH)2]Z2
wherein L is 2,2′-bis[bis(4-dimethylaminophenyl)phosphino]-1,1′-binaphthyl, 2,2′-bis[bis(4-dimethylamino-3,5-dimethylphenyl)phosphino]-1,1′-binaphthyl, 2,2′-bis[bis(4-dimethylamino-3,5-diethylphenyl)phosphino]-1,1′-binaphthyl, 2,2′-bis[bis(4-dimethylamino-3,5-diisopropylphenyl)phosphino]-1,1′-binaphthyl, 2,2′-bis[bis(4-diethylaminophenyl)phosphino]-1,1′-binaphthyl or 2,2′-bis[bis[4-(pyrrolidin-1-yl)phenyl]phosphino]-1,1′-binaphthyl, Ac is acetyl, dmf is N,N-dimethylformamide, n is an integer of not less than 1, Ar is benzene optionally having substituent(s), 2-methylallyl is η3-2-methylallyl, X is ethylenediamine, 1,2-diphenylethylenediamine or 1,1-di(4-anisyl)-2-isopropyl-1,2-ethylenediamine, Y is 1,5-cyclooctadiene or norbornadiene, Z is a counter anion and trifluoromethanesulfonate, tetrafluoroborate, perchlorate, hexafluorophosphate or tetraphenylborate.

### Claim 11 (depends on 6)

A catalyst comprising the transition metal complex of claim 6.

### Claim 12

A compound represented by the formula
wherein R4a is a hydrogen atom or a C1-6 alkyl group optionally having substituent(s), and R5a and R6a are each a C1-6 alkyl group optionally having substituent(s), or the formula
is a group represented by the formula
wherein ring B′ is a 3- to 8-membered ring optionally having substituent(s), provided that bis(4-dimethylaminophenyl)phosphine-borane complex is excluded, or a salt thereof.

### Claim 13 (depends on 12)

The compound of claim 12, wherein R4a, R5a and R6a are each a C1-6 alkyl group optionally having substituent(s).

### Claim 14 (depends on 2)

The compound of claim 2, which is an optically active compound.

### Claim 15 (depends on 3)

The compound of claim 3, which is an optically active compound.

### Claim 16 (depends on 4)

The compound of claim 4, which is an optically active compound.
